论文信息 - Paradoxical vascular–fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity - 字舞流文

Paradoxical vascular–fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity

L. C. Zepeda-Romero | J. A. Gutiérrez-Padilla | J. A. Liera-Garcia | C. I. Valtierra-Santiago | C. D. Avila-Gómez

[1] H. Hosseini,et al. Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. , 2009, Retina.

[2] R. Penland,et al. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study. , 2008, Archives of ophthalmology.

[3] T. Fujikado,et al. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study , 2008, British Journal of Ophthalmology.

[4] A. Negi,et al. Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[5] C. Puliafito,et al. OFF-LABEL USE OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR SALVAGE TREATMENT IN PROGRESSIVE THRESHOLD RETINOPATHY OF PREMATURITY , 2008, Retina.

[6] D. Coats,et al. Involution of Threshold Retinopathy of Prematurity after Diode Laser Photocoagulation , 2004 .

[7] A. Negi,et al. Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy , 2009, Eye.